USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	052456/0343			Pages:	12
		Recorded:	04/21/2020
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 13

Patent #:	7709227	Issue Dt:	05/04/2010	Application #:	11620034	Filing Dt:	01/04/2007
Publication #:	US20080032400	Pub Dt:	02/07/2008
Title:	MULTIMERIC ELP FUSION CONSTRUCTS

Patent #:	9029505	Issue Dt:	05/12/2015	Application #:	12857103	Filing Dt:	08/16/2010
Publication #:	US20110178017	Pub Dt:	07/21/2011
Title:	MODIFIED VASOACTIVE INTESTINAL PEPTIDES

Patent #:	NONE	Issue Dt:		Application #:	14099590	Filing Dt:	12/06/2013
Publication #:	US20140171370	Pub Dt:	06/19/2014
Title:	FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

Patent #:	9561262	Issue Dt:	02/07/2017	Application #:	14124612	Filing Dt:	11/04/2014
Publication #:	US20150111829	Pub Dt:	04/23/2015
Title:	USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION

Patent #:	9700598	Issue Dt:	07/11/2017	Application #:	14681597	Filing Dt:	04/08/2015
Publication #:	US20160220642	Pub Dt:	08/04/2016
Title:	MODIFIED VASOACTIVE INTESTINAL PEPTIDES

Patent #:	10940182	Issue Dt:	03/09/2021	Application #:	15276151	Filing Dt:	09/26/2016
Publication #:	US20170072021	Pub Dt:	03/16/2017
Title:	USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION

Patent #:	11052132	Issue Dt:	07/06/2021	Application #:	15308626	Filing Dt:	11/03/2016
Publication #:	US20170182130	Pub Dt:	06/29/2017
Title:	METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS

Patent #:	9919032	Issue Dt:	03/20/2018	Application #:	15355386	Filing Dt:	11/18/2016
Publication #:	US20170136092	Pub Dt:	05/18/2017
Title:	A METHOD FOR ADMINISTERING A SUSTAINED RELEASE FORMULATION

Patent #:	10722590	Issue Dt:	07/28/2020	Application #:	15527985	Filing Dt:	05/18/2017
Publication #:	US20190015523	Pub Dt:	01/17/2019
Title:	ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

Patent #:	10688156	Issue Dt:	06/23/2020	Application #:	15546037	Filing Dt:	07/25/2017
Publication #:	US20180333467	Pub Dt:	11/22/2018
Title:	METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	15621320	Filing Dt:	06/13/2017
Publication #:	US20180008677	Pub Dt:	01/11/2018
Title:	MODIFIED VASOACTIVE INTESTINAL PEPTIDES

Patent #:	NONE	Issue Dt:		Application #:	16099261	Filing Dt:	11/06/2018
Publication #:	US20190218274	Pub Dt:	07/18/2019
Title:	ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

Patent #:	11040034	Issue Dt:	06/22/2021	Application #:	16124846	Filing Dt:	09/07/2018
Publication #:	US20190008861	Pub Dt:	01/10/2019
Title:	METALLOENZYME INHIBITOR COMPOUNDS

Assignor

Exec Dt:

03/19/2020

Assignee

3003 TASMAN DRIVE

SANTA CLARA, CALIFORNIA 95054

Correspondence name and address
	DLA PIPER LLP (US)
	401 B STREET, SUITE 1700
	SAN DIEGO, CA 92101

Search Results as of: 05/29/2024 08:59 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6